[Prophylactic and sensitizing effects of biologically active substances in animal modeling of vestibular disorders].
Shashkov
V S
VS
Drozd
Iu V
IuV
Puko
V M
VM
D000818:Animals; D000932:Antiemetics / Q000008:administration & dosage / Q000627:therapeutic use; D002415:Cats; D003701:Delta Sleep-Inducing Peptide / Q000008:administration & dosage / Q000627:therapeutic use; D004723:Endorphins / Q000008:administration & dosage / Q000627:therapeutic use; D004743:Enkephalin, Leucine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D006220:Haloperidol / Q000008:administration & dosage / Q000627:therapeutic use; D008012:Lidocaine / Q000008:administration & dosage / Q000627:therapeutic use; D008784:Methysergide / Q000008:administration & dosage / Q000627:therapeutic use; D009041:Motion Sickness / Q000188:drug therapy / Q000517:prevention & control*; D009270:Naloxone / Q000008:administration & dosage / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D051381:Rats; D012601:Scopolamine / Q000008:administration & dosage / Q000627:therapeutic use; D012702:Serotonin Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D014810:Vitamin E / Q000008:administration & dosage / Q000627:therapeutic use
D000932:Antiemetics; D004723:Endorphins; D009292:Narcotic Antagonists; D012702:Serotonin Antagonists; D014810:Vitamin E; D009270:Naloxone; D004743:Enkephalin, Leucine; D003701:Delta Sleep-Inducing Peptide; C036405:ICI 154129; D008012:Lidocaine; D012601:Scopolamine; D006220:Haloperidol; D008784:Methysergide
Profilakticheskoe i sensibiliziruiushchee deĭstvie biologicheski aktivnykh veshchestv pri modelirovanii vestibulovegetativnykh rasstroĭstv.